Amanda Psyrri

Research interests

Publications

• Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

  Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.21.02508

• Pembrolizumab alone or with chemotherapy for recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by Programmed Death Ligand-1 combined positive score

  Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · 2022

• Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(20)30737-3

• Immunotherapy for pancreatic cancer: A 2020 update

  Cancer Treatment Reviews · 2020 · https://doi.org/10.1016/j.ctrv.2020.102016

• Biomarkers for immunotherapy response in head and neck cancer

  Cancer Treatment Reviews · 2020 · https://doi.org/10.1016/j.ctrv.2020.101977

• Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32591-7

• Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting

  Frontiers in Oncology · 2019 · https://doi.org/10.3389/fonc.2019.00827

• Medical management of gastric cancer: a 2017 update

  Cancer Medicine · 2017 · https://doi.org/10.1002/cam4.1274

• Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx206

• ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

  Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-17-1181

• Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma

  Clinical Cancer Research · 2015 · https://doi.org/10.1158/1078-0432.ccr-15-1543

• Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis

  Cancer Treatment Reviews · 2015 · https://doi.org/10.1016/j.ctrv.2015.10.002

• Beyond BRCA: New hereditary breast cancer susceptibility genes

  Cancer Treatment Reviews · 2014 · https://doi.org/10.1016/j.ctrv.2014.10.008

• Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

  Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdt574

• Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.

  Head & Neck · 2009 · https://doi.org/10.1002/hed.21269

• Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2004.00.3335

• Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis

  Clinical Cancer Research · 2005 · https://doi.org/10.1158/1078-0432.ccr-05-0420

• Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer

  Clinical Cancer Research · 2004 · https://doi.org/10.1158/1078-0432.ccr-04-0448

Current projects

No projects listed.